TFFP (TFF Pharmaceuticals, Inc.) מחיר לרווח עתידי

TFF Pharmaceuticals relies on a unique drug-freezing powder platform through B2B contracts. The issuer's expected P/E on the GURU.Markets chart reflects market sentiment, with the indicator reaching 0.00. While the company is valued for converting injections into inhalations, delisting risks and a liquidity shortage are exerting significant pressure on the stock price.

The forward P/E determines the fair value of assets by correlating the current market share price with the projected net income for the upcoming period. By analyzing the current forward P/E of TFF Pharmaceuticals (TFFP), an investor assesses market expectations for the monetization of thin-film freezing technology, where the potential for long-term royalties from platform licensing drives the coefficient's dynamics and the search for a balance between risks and future earnings.